|
|
Timeframe
|
|
|
Category
|
|
|
Sub-Category
|
|
|
** To make multiple selections, select the first criterion and then press and hold
the Ctrl Key **
|
|
|
1- 1 of 1
Search Results for:
|
Ordering of Search Results
When searching across multiple libraries:
FAQs will appear in alphabetical order by category and sub-category
Listing Council Decisions will appear in reverse chronological order by year.
Staff Interpretations will appear in reverse chronological order by year
When searching using keywords:
Results are returned in order of term frequency (i.e., the number of times the keywords appear in the material).
|
Libraries:  
Staff Interpretation Letters
|
Filters:  
All Years; Shareholder Approval; All
|
|
|
|
Identification Number
880
|
|
This is in response to your letters regarding the applicability of The NASDAQ Stock Market’s shareholder approval requirements to an issuance of securities in a private placement (the “Transaction”). Specifically, you asked about the potential applicability
of Marketplace Listing Rule 4350(i)(1)(B) (the “Rule”).
According to the information you provided, in the Transaction the company expects to issue to institutional investors shares (the “Shares”) equal to approximately 12.5% to 15.7% of the pre-transaction outstanding shares of common stock, at a discount to
the market value. No officer, director, employee, or consultant of the company will participate in the Transaction. Among the investors who may participate is “Fund”, which currently owns approximately 21% of the company’s outstanding common stock. The
Fund acquired its holdings by participating in private placements and by open market purchases. Currently, no other stockholder or group of affiliated stockholders, including the company’s officers and directors as a group, has a larger beneficial ownership
interest in the company’s common stock than the Fund, and according to the company’s last proxy statement, no other investor holds a position as large as 5% of the company’s common stock. Depending on its level of participation, the Fund’s holdings in the
company may go up or down, or even remain constant, as a result of the Transaction. No other stockholder or group of stockholders will have a larger interest in the company than the Fund following the Transaction.
Following our review of the information you submitted, we have concluded that the Transaction, as described in your correspondence, does not require shareholder approval under the Rule because it will not result in a change of control. The Fund, the largest
current shareholder, will remain the largest shareholder upon the completion of the Transaction, and there is no other significant shareholder. Further, at the time the Fund made the open market purchases that resulted in its ownership increasing from approximately
18% to approximately 21%, the company had not had any discussions with the Fund regarding the Transaction or other equity financing.
Publication Date*:
7/31/2012
|
|
|
Identification Number:
880
|
|
|
|
|